Literature DB >> 2466474

Vitronectin (S protein) is associated with platelets.

C J Parker1, O L Stone, V F White, N J Bernshaw.   

Abstract

Vitronectin is a plasma glycoprotein that has regulatory activity in the complement and the coagulation systems, in cell-cell and cell-substrate interactions, and in monocyte/macrophage function. Because of its potential to participate in several of the processes of inflammation and repair, the association of vitronectin with platelets was investigated. Immunochemical studies demonstrated that the majority of the platelet associated vitronectin was intracellular, while a relatively modest amount was localized to the ectoplasmic portion of the plasma membrane. Analysis by Western blot showed that the electrophoretic mobility of platelet associated vitronectin was indistinguishable from that of vitronectin isolated from plasma. In response to thrombin, approximately 1 microgram of vitronectin was released into the supernate of 10(9) platelets, while somewhat less than one-half of the total platelet vitronectin remained cell associated. The binding of vitronectin to platelets was investigated by comparing the capacity of unlabelled vitronectin and fibronectin to inhibit binding of radiolabelled fibronectin to thrombin stimulated platelets. On a weight basis, inhibition by the two proteins was equivalent, suggesting that vitronectin competes with fibronectin for binding to platelet glycoprotein IIb/IIIa. These results demonstrate that vitronectin is a platelet specific protein which, because of its multifunctional properties, may participate in physiological and pathophysiological events associated with thrombosis and haemostasis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466474     DOI: 10.1111/j.1365-2141.1989.tb04262.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  The significance of vitronectin in proliferative diabetic retinopathy.

Authors:  P Esser; M Bresgen; M Weller; K Heimann; P Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-08       Impact factor: 3.117

2.  Correlation of Serum Levels of Vitronectin, Malondialdehyde and Hs- CRP With Disease Severity in Coronary Artery Disease.

Authors:  Alireza Yaghoubi; Morteza Ghojazadeh; Sakhavat Abolhasani; Hossein Alikhah; Fatemeh Khaki-Khatibi
Journal:  J Cardiovasc Thorac Res       Date:  2015

3.  Protein disulfide isomerase secretion following vascular injury initiates a regulatory pathway for thrombus formation.

Authors:  Sheryl R Bowley; Chao Fang; Glenn Merrill-Skoloff; Barbara C Furie; Bruce Furie
Journal:  Nat Commun       Date:  2017-02-20       Impact factor: 14.919

4.  Serum proteomic analysis reveals high frequency of haptoglobin deficiency and elevated thyroxine level in heroin addicts.

Authors:  Bing-Ying Zhou; Shi-Yan Yan; Wan-Lu Shi; Zhi Qu; Xin Zhao; Zhi-Min Liu; Xiao-Ping Pu
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

5.  Concerted functions of Streptococcus gordonii surface proteins PadA and Hsa mediate activation of human platelets and interactions with extracellular matrix.

Authors:  Jennifer A Haworth; Howard F Jenkinson; Helen J Petersen; Catherine R Back; Jane L Brittan; Steve W Kerrigan; Angela H Nobbs
Journal:  Cell Microbiol       Date:  2016-10-11       Impact factor: 3.715

Review 6.  Role of platelets and platelet receptors in cancer metastasis.

Authors:  Martin Schlesinger
Journal:  J Hematol Oncol       Date:  2018-10-11       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.